Kalyan Jewellers India (KALYANKJIL.NS) traded down -3.47 % during a 24 hours period ending at 09:22 PM Central Europe on Monday 26th. One Kalyan Jewellers India stock can currently be bought for about INR 504.8 on popular exchanges. Current supply of Kalyan Jewellers India stocks is 1 bn. Kalyan Jewellers India has a current market capitalization of INR 528.8 bn and approximately INR 2.6 bn worth of Kalyan Jewellers India was traded on exchanges in the last 24 hours. Since last month end, Kalyan Jewellers India has traded -10.74 % down. Simple moving average of last 200 days is at INR 464.91. The highest price of past 52 weeks was recorded at INR 648.95 on 07/30/2026. 52 weeks low was at INR 327.05 on 06/11/2026.
Summary of the latest news for Kalyan Jewellers India
Kalyan Jewellers India Ltd is scheduled to release its financial results for the quarter ended 30 September 2026 at its upcoming quarterly conference on 10 November. Analysts anticipate a modest rise in earnings per share compared with the previous year, alongside a notable increase in revenue for the quarter. Projections for the current fiscal year also suggest growth in both earnings and sales relative to the prior year. The company’s forthcoming disclosures are expected to clarify these estimates and provide insight into its ongoing performance.
Here is how related stocks have performed in the past 24 hours:
Prestige Estates Projects (PRESTIGE.NS) traded down -2.62 % and now trades at INR 1,396.6. Current market capitalisation for Prestige Estates Projects is INR 599.8 bn. Prestige Estates Projects has a current price to earnings ratio of 54.64. Prestige Estates Projects, a prominent real‑estate developer, remains a key holding in several mid‑cap funds, notably in the Invesco India Midcap Fund, where it accounts for roughly seven percent of the portfolio. The fund, which focuses on growth‑oriented mid‑cap companies, has demonstrated a strong long‑term track record, outperforming many peers over five years. Its portfolio is diversified across sectors, with significant exposure to pharma, healthcare, retail, banking, realty, and automotive ancillary businesses. While the fund’s performance has experienced periodic volatility, it has consistently recovered and achieved competitive risk‑adjusted returns. The emphasis on quality, stable business models, and a blend of mid‑cap, large‑cap, and small‑cap investments has helped the fund navigate market fluctuations, maintaining a balanced exposure to growth opportunities.
Alkem Laboratories (ALKEM.NS) traded down -1.33 % and now trades at INR 5,030. Alkem Laboratories has a market capitalisation of INR 591.5 bn. Current price/earnings ratio for Alkem Laboratories is 27.79.
Glenmark (GLENMARK.NS) traded down -1.45 % and now trades at INR 2,225.8. Glenmark has a market capitalisation of INR 611.5 bn. Current price/earnings ratio for Glenmark is 34.45.
Bank Of India (BANKINDIA.NS) traded down -3.82 % and now trades at INR 126.32. Current market capitalisation for Bank Of India is INR 596.4 bn. Current price/earnings ratio for Bank Of India is 5.34.
Icici Prudential Life Insura (ICICIPRULI.NS) traded down -0.12 % and now trades at INR 431. Icici Prudential Life Insura has a market capitalisation of INR 625.3 bn. Icici Prudential Life Insura has a current price to earnings ratio of 42.41.